朕天下娛樂城
Invest in 朕天下娛樂城
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
STAR ?NSE
Strides Pharma Science
?1,110.900.10 (0.01%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
1,095.00
Today’s high
1,122.00
52 week low
768.65
52 week high
1,231.00
Open price
1,095.00
Previous close
1,110.80
Live volume
68,321
Lower circuit
888.70
Upper circuit
1,332.90
Fundamentals
Market Cap
?10,204Cr
ROE
17.90%
P/E Ratio(TTM)
17.76
EPS(TTM)
62.33
P/B Ratio
3.28
Dividend Yield
0.45%
Industry P/E
33.85
Book Value
337.15
Debt to Equity
0.57
Face Value
10
Financial performance
MAR '26
Revenue (Cr)
?1,332
+2.31%
Profit (Cr)
?129
-37.88%
04008001.2k1.6k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +11% |
| 3Y CAGR | +13% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +51% |
| 3Y CAGR | +42% |
About
Strides is a global pharmaceutical company that makes high-quality, affordable generic medicines for markets across the world. The company's vision is to become a leading Indian multinational pharmaceutical firm known for its superior quality and integrity. Its operations have a significant global footprint, reaching healthcare systems in over 100 countries worldwide.;
CEO/MD
Dr. R. Ananthanarayanan
Founded in
--
NSE symbol
STAR
Shareholding Pattern
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Mutual Funds Invested (3)
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ?8,433.50 -95.50 (1.12%) | 21,286.25 | 113.51 | 24.39 | ||
PfizerPFIZER | ?4,533.70 -5.60 (0.12%) | 20,766.73 | 28.74 | 4.94 | ||
?1,448.40 +17.80 (1.24%) | 19,822.74 | 30.61 | 5.08 | |||
Granules IndiaGRANULES | ?786.90 +4.80 (0.61%) | 19,386.39 | 32.58 | 3.81 |
Livesquawk ?
Strides Pharma gets NCLT approval for Arcus Labs' spin-off into Pivot Path.
Pivot Path, focusing on life sciences and digital innovation, will be fully owned by Strides.
Livesquawk ?
Strides Pharma announces Sandoz contributions starting H2 FY27.
Livesquawk ?
Strides Pharma targets $400M North American revenue by FY28 despite current challenges.
The company anticipates growth resumption by H2FY27 as conditions improve.
2026
18
May
Annual Result
Release date
30
Jan
Quarterly Result
Release date
2025
31
Oct
Quarterly Result
Release date
29
Jul
Quarterly Result
Release date
22JulDividendEx date?4.00per share
22
Jul
Dividend
Ex date
?4.00
per share
For each share you hold, you will receive ?4.00
Dividend amount?4.00 per share
Dividend TypeFinal
Ex Date22 Jul ‘25
Record Date22 Jul ‘25
Announcement date22 May ‘25
22MayDividendAnnounced?4.00per share
22
May
Dividend
Announced
?4.00
per share
For each share you hold, you will receive ?4.00
Dividend amount?4.00 per share
Dividend TypeFinal
Ex Date22 Jul ‘25
Record Date22 Jul ‘25
Announcement date22 May ‘25
2024
6DecDemerger into OneSource Specialty Pharma LtdEx date
6
Dec
Demerger into OneSource Specialty Pharma Ltd
Ex date
Demerger into OneSource Specialty Pharma Ltd.
For every 2 shares you hold of the parent company undergoing demerger, you will receive 1 shares in the new demerged company.
Ex date6 Dec ‘24
Record date6 Dec ‘24
Announcement date25 Sep ‘23
Ratio2:1
9SepDividendEx date?2.50per share
9
Sep
Dividend
Ex date
?2.50
per share
For each share you hold, you will receive ?2.50
Dividend amount?2.50 per share
Dividend TypeFinal
Ex Date9 Sep ‘24
Record Date9 Sep ‘24
Announcement date22 May ‘24
Events calendar
View upcoming events in other stocks